查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386584

移植HLA型檢測市場報告：2030 年趨勢、預測與競爭分析

HLA Typing for Transplant Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

移植HLA型檢測的趨勢與預測

到 2030 年，全球可移植HLA型檢測市場預計將達到 13 億美元，2024 年至 2030 年年複合成長率為 8.2%。該市場的主要驅動力是器官移植手術數量的增加、移植醫學的持續進步以及自體免疫疾病盛行率的增加。全球HLA型檢測移植市場的未來充滿希望，獨立參考實驗室、醫院和移植中心、實驗室和學術機構市場都有機會。

移植HLA型檢測市場洞察

Lucintel 預測，由於快速處理樣本的高通量、檢測多種 HLA 等位基因的能力以及卓越的準確性，分子分型將繼續成為較大的細分市場。

由於擁有強大的醫療基礎設施、先進移植診斷技術的廣泛接受度以及該地區主要參與者的存在，北美將繼續成為最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球移植市場HLA型檢測：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球移植市場的HLA型檢測趨勢（2018-2023年）與預測（2024-2030年）
  • 按產品類型HLA型檢測移植分型
    • 試劑/消耗品
    • 裝置
    • 軟體服務
  • 透過科技進行全球移植的HLA型檢測
    • 分子檢測技術
    • 非分子檢測技術
  • 按應用進行移植的全球HLA型檢測
    • 診斷
    • 研究
    • 其他
  • 按最終用途產業HLA型檢測
    • 獨立參考實驗室
    • 醫院/移植中心
    • 研究/學術機構
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的用於移植的全球HLA型檢測
  • 北美用於移植的HLA型檢測
  • 歐洲移植的HLA型檢測
  • 亞太地區用於移植的HLA型檢測
  • 用於其他地區移植的HLA型檢測

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球HLA型檢測分型移植市場成長機會
    • 全球HLA型檢測技術帶來的移植市場成長機會
    • 全球HLA型檢測移植市場成長機會（按應用）
    • 全球移植HLA型檢測市場成長機會（依最終用途產業分類）
    • 按地區分類的全球移植HLA型檢測市場成長機會
  • 全球移植市場HLA型檢測的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球移植HLA型檢測市場的產能擴張
    • 全球移植HLA型檢測市場的合併與收購企業
    • 認證和許可

第7章 主要企業概況

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche
簡介目錄

HLA Typing for Transplant Trends and Forecast

The future of the global HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets. The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.

A more than 150-page report is developed to help in your business decisions.

HLA Typing for Transplant by Segment

The study includes a forecast for the global HLA typing for transplant by product type, technology, application, end use industry, and region.

HLA Typing for Transplant Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents and Consumables
  • Instruments
  • Software and Services

HLA Typing for Transplant Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Molecular Assay Technologies
  • Non- Molecular Assay Technologies

HLA Typing for Transplant Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic
  • Research
  • Others

HLA Typing for Transplant Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Independent Reference Laboratories
  • Hospitals and Transplant Centres
  • Research Laboratories and Academic Institutes
  • Others

HLA Typing for Transplant Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of HLA Typing for Transplant Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HLA typing for transplant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HLA typing for transplant companies profiled in this report include-

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche

HLA Typing for Transplant Market Insights

Lucintel forecasts that molecular will remain the larger segment due to its high throughput for the quick processing of samples, ability to detect wide variety of HLA alleles, and excellent accuracy.

North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.

Features of the Global HLA Typing for Transplant Market

Market Size Estimates: HLA typing for transplant market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HLA typing for transplant market size by various segments, such as by product type, technology, application, end use industry, and region in terms of ($B).

Regional Analysis: HLA typing for transplant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end use industries, and regions for the HLA typing for transplant market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HLA typing for transplant market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the HLA typing for transplant market size?

Answer: The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030.

Q.2 What is the growth forecast for HLA typing for transplant market?

Answer: The global HLA typing for transplant market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the HLA typing for transplant market?

Answer: The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.

Q4. What are the major segments for HLA typing for transplant market?

Answer: The future of the HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets.

Q5. Who are the key HLA typing for transplant market companies?

Answer: Some of the key HLA typing for transplant companies are as follows:

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche

Q6. Which HLA typing for transplant market segment will be the largest in future?

Answer: Lucintel forecasts that molecular will remain the larger segment due to its high throughput for the quick processing of samples, ability to detect wide variety of HLA alleles, and excellent accuracy.

Q7. In HLA typing for transplant market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the HLA typing for transplant market by product type (reagents and consumables, instruments, and software and services), technology (molecular assay technologies and non- molecular assay technologies), application (diagnostic, research, and others), end use industry (independent reference laboratories, hospitals and transplant centres, research laboratories and academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HLA Typing for Transplant Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global HLA Typing for Transplant Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global HLA Typing for Transplant Market by Product Type
    • 3.3.1: Reagents and Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software and Services
  • 3.4: Global HLA Typing for Transplant Market by Technology
    • 3.4.1: Molecular Assay Technologies
    • 3.4.2: Non- Molecular Assay Technologies
  • 3.5: Global HLA Typing for Transplant Market by Application
    • 3.5.1: Diagnostic
    • 3.5.2: Research
    • 3.5.3: Others
  • 3.6: Global HLA Typing for Transplant Market by End Use Industry
    • 3.6.1: Independent Reference Laboratories
    • 3.6.2: Hospitals and Transplant Centres
    • 3.6.3: Research Laboratories and Academic Institutes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global HLA Typing for Transplant Market by Region
  • 4.2: North American HLA Typing for Transplant Market
    • 4.2.1: North American HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.2.2: North American HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.3: European HLA Typing for Transplant Market
    • 4.3.1: European HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.3.2: European HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.4: APAC HLA Typing for Transplant Market
    • 4.4.1: APAC HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.4.2: APAC HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.5: ROW HLA Typing for Transplant Market
    • 4.5.1: ROW HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.5.2: ROW HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global HLA Typing for Transplant Market by Product Type
    • 6.1.2: Growth Opportunities for the Global HLA Typing for Transplant Market by Technology
    • 6.1.3: Growth Opportunities for the Global HLA Typing for Transplant Market by Application
    • 6.1.4: Growth Opportunities for the Global HLA Typing for Transplant Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global HLA Typing for Transplant Market by Region
  • 6.2: Emerging Trends in the Global HLA Typing for Transplant Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global HLA Typing for Transplant Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HLA Typing for Transplant Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Bio-Rad Laboratories
  • 7.3: Qiagen
  • 7.4: Omixon
  • 7.5: GenDx
  • 7.6: Illumina
  • 7.7: TBG Diagnostics
  • 7.8: Dickinson
  • 7.9: Takara Bio
  • 7.10: F. Hoffman-La Roche